Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre

CarolL Shields, Zeynep Bas, Sameeksha Tadepalli, Lauren A Dalvin, Raksha Rao, Rachel Schwendeman, Sara E Lally, Jerry A Shields, Amish Shah, Ann Leahey

Read More

Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients

Lauren A. Dalvin, MD; Zeynep Bas, MD; Sameeksha Tadepalli, MD; Raksha Rao, MD; Sarangdev Vaidya, BA; Richard Pacheco, BA; Carol L. Shields, MD

Read More

Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds

David H Abramson, Xunda Ji, Jasmine H Francis, Federica Catalanotti, Scott E Brodie, Larissa Habib

Read More

https://bjo.bmj.com/content/103/4/488

Retrospective analysis of primarily treated group D retinoblastoma

Hayyam Kiratli, İrem Koç, Onur Inam, Ali Varan, Canan Akyüz

Read More

https://link.springer.com/article/10.1007/s00417-018-4051-4